66
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Hyaluronidase-injectable microparticles intended for the treatment of extravasation

, , , , , & show all
Pages 85-92 | Received 03 Jul 1996, Accepted 20 Apr 1997, Published online: 27 Sep 2008

References

  • Amado R., Ingmar B., Lindhall U., Wateson A. Depolymerization and desulfuration of chondroitin sulfate by enzymes from embryonic chick cartilage. FEBS Letters. 1974; 39: 49–54
  • Akin H., Hasirci N. Preparation and characterization of cross-linked gelatin microspheres. Journal of Applied Polymer Science 1995; 58: 95–100
  • Ayalon A., Anner H., Berlatzky Y., Schiller M. A life threatening complication of the infusion pump. Lancet, i 1978; 853–854
  • Bertelli G., Dini D., Forno G. B., Gozza A., Silvestro S., Venturini M., Rosso R., Pronzato P. Hyaluronidase as antidote to extravasation of Vinca alkaloids: clinical results. Journal of Cancer Research and Clinical Oncology 1994; 120: 505–506
  • Bowers D. G., Jr, Lynch J. B. Adriamycin extravasation. Plastic Reconstruction Surgery 1978; 61: 86–92
  • Burgess D. J., Davis S. S., Tomlinson E. Potential use of albumin microspheres as a drug delivery system. I. Preparation and in vitro release of steroids. International Journal of Pharmacology 1987; 39: 129–136
  • Eli Lilly & Co. Official Product Monograph. Scarborough, Ontario 1982
  • Hascall V. C., Calabro A., Midura R. J., Yanagishita M. Guide to techniques in microbiology. Methods in Enzymology, W. J. Lennart, G. W. Hart. New York Academic. 1994; 390–417
  • Ignoffo R. J., Friedman M. A. Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treatment Reviews 1980; 7: 17–27
  • Jayakrishnan A., Jameela S. R. Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices. Biomaterials 1996; 17: 471–484
  • Lowry O. H., Rosebrough N. J., Lewis Farr A., Randall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–70
  • MacCara M. E. Extravasation: a hazard of intravenous therapy. Drug Zntell. Clin. Pharm. 1983; 17: 713–717
  • Michalski J. C., Olavesen A. H., Winterburn P. J., Pope D. J., Strecker G. The stucture of the major oligosaccharide unit of bovine testicular hyaluronidase. Biochemical Society Transaction 1984; 12: 657–658
  • Register T. C., Wagner W. D. Heterogeneity in glycosylation of derrnatan sulfate proteoglycan core proteins isolated from human aorta. Connective Tissue Research 1990; 25: 35–48
  • Renaudin M. C., Combe M., Sauvageon A. Extravasation en cherniotherapie anticancerose: antidotes et attitude pratique. Le Pharmac. Hosp. 1991; 106: 71–75
  • Torrado J. J., Illum L., Davis S. S. Particle size and size distribution of albumin microspheres produced by heat and chemical stabilization. International Journal of Pharmacology 1989; 51: 85–93
  • Upton J., Mulliken J. B., Murray J. E. Major intravenous extravasation injuries. American Journal of Surgery 1979; 137: 497–506
  • Wessler E. Analytical and preparative separation of acidic glycosarninoglycans by electrophoresis in barium acetate. Anals of Biochemistry 1968; 26: 439–444
  • Zeng X. M., Martin G. P., Marriot C. Preparation and in vitro evaluation of tetrandrine-entrapped albumin microspheres as an inhaled drug delivery system. European Journal of Pharmaceutical Science 1995; 3: 87–93

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.